Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-009444
Filing Date
2018-04-04
Accepted
2018-04-04 16:24:36
Documents
1
Period of Report
2018-04-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7042
  Complete submission text file 0000899243-18-009444.txt   9142
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Reporting) CIK: 0001114448 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38433 | Film No.: 18737485
SIC: 2834 Pharmaceutical Preparations

Mailing Address 45 WIGGINS AVE. BEDFORD MA 01730
Business Address 45 WIGGINS AVE. BEDFORD MA 01730 857-305-1825
Homology Medicines, Inc. (Issuer) CIK: 0001661998 (see all company filings)

EIN.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 250 MASSACHUSETTS AVENUE CAMBRIDGE MA 02139
Business Address 250 MASSACHUSETTS AVENUE CAMBRIDGE MA 02139 (617) 871-8000
Novartis Institutes for BioMedical Research, Inc. (Reporting) CIK: 0001673852 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38433 | Film No.: 18737486